Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2903)
All Articles published online
|
Publishing Process of This Article
|
Jun 26, 2022 (publication date) through Jul 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun SJ, Han JD, Liu W, Wu ZY, Zhao X, Yan X, Jiao SC, Fang J. Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer. World J Clin Cases 2022; 10(18): 6069-6081 [PMID: 35949840 DOI: 10.12998/wjcc.v10.i18.6069] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i18/6069.htm |
| Number | Citing Articles |
| 1 |
Jianchao Xue, Bowen Li, Yadong Wang, Zhicheng Huang, Xinyu Liu, Chao Guo, Zhibo Zheng, Naixin Liang, Xiuning Le, Shanqing Li. Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis. Cancers 2022; 14(19): 4894 doi: 10.3390/cancers14194894
|
| 2 |
Xiaotong Song, Luchang Cao, Baoyi Ni, Jia Wang, Xiaoyan Qin, Xiaoyue Sun, Bowen Xu, Xinmiao Wang, Jie Li. Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1090500
|